The rising interest in GLP-1 agonists for diabetes has sparked a question about application forms : skin-applied devices versus pills . Usually , GLP-1 treatments were solely available in pill form, but the https://albertokem772901.blogsumer.com/39886176/glp-1-transdermal-delivery-systems-vs-oral-medications-what-suitable-for-individuals